Join the club for FREE to access the whole archive and other member benefits.


Genomic intelligence solutions

Genomenon is a genomic intelligence company headquartered in Ann Arbor, Michigan. Founded in 2014 by Dr. Mark Kiel, it specializes in variant interpretation for rare diseases and cancer. Their Mastermind Genomic Intelligence Platform is a comprehensive source of published genomic evidence, aiding in diagnostics and therapeutics development. The platform was detailed in a research paper published in November 2020. Genomenon's leadership includes CEO Mike Klein, CSO & Co-founder Dr. Mark J. Kiel, and a team with extensive experience in genomics, software development, and sales. Their core values emphasize continuous learning, data-driven decisions, customer focus, humility, and perseverance.

Visit website:




Details last updated 02-Apr-2024

Genomenon News

Genomenon develops AI-powered tool to uncover links between genes and diseases

Inside Precision Medicine - 15-Mar-2024

This new technology could improve the accuracy of genetic testing